Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a specialty pharmaceutical company, is committed to providing prescription drugs designed to address central nervous system (CNS) disorders. Currently, the company is building a core portfolio of both marketed and development-stage products that attend to substantial, but unmet medical needs. Questcor’s aim is to develop and commercialize their own proprietary products, while staying open to partnering concepts to leverage assets and further build its portfolio. For further information, visit the Company’s web site at www.questcor.com.
- 17 years ago
QualityStocks
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Numa Numa Resources Inc. Positioned at Nexus of Copper Supply Shift
Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. As copper emerges as…
-
QualityStocksNewsBreaks – Superstate/Forward Industries Inc. (NASDAQ: FWDI) Launch Unlocks Full DeFi Potential for Public Shares
Forward Industries (NASDAQ: FWDI), a company that is building and managing a large-scale Solana (“SOL”)…
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…